To test this, CAFs were isolated from human tumors (HNSCC, EAC, CRC, and non–small cell lung cancer [NSCLC]) and treated with GKT137831 or shRNA to inhibit NOX4. Here, NOX4 is linked to head and neck squamous cell carcinoma.